CLOSE ×
×

Gemcitabine and 2’,2’-Difluoro-2’-Deoxyuridine (dFdU) Metabolite

Inotiv
Analyte
Gemcitabine and 2’,2’-Difluoro-2’-Deoxyuridine (dFdU) Metabolite
Species
Human
Matrix
Plasma (THU-treated)
Anticoagulant
Heparin
Instrument
LC-MS/MS
Isotope
Yes
Aliquot Volume
20 µl
LLOQ-ULOQ
50-50000 ng/mL
Storage Temperature
-20 and/or -80°C
Status
Active

Examples in Scientific Literature

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial

Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer

Tags: antimetabolite, cancer, chemotherapy, Gemzar®, pyrimidine nucleoside prodrug, ribonucleotide reductase inhibitor

BASi Method Number SAP.1849

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now  

Copyright © 2024 Inotiv. All Rights Reserved.